Literature DB >> 4735211

Immunosuppression and cancer.

I Penn, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4735211      PMCID： PMC2840634     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

Review 1.  Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy.

Authors:  T E Starzl; I Penn; C W Putnam; C G Groth; C G Halgrimson
Journal:  Transplant Rev       Date:  1971

2.  De novo malignant tumors in organ transplant recipients.

Authors:  I Penn; C G Halgrimson; T E Starzl
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066
  2 in total
  31 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part II.

Authors:  R G Shorter; D A Shephard
Journal:  Am J Dig Dis       Date:  1975-07

2.  The role of the immune response in oncogenesis.

Authors:  H F Jeejeebhoy
Journal:  In Vitro       Date:  1975 May-Jun

3.  Systemic glucocorticoid use and early-onset basal cell carcinoma.

Authors:  Jose Ramon Troche; Leah M Ferrucci; Brenda Cartmel; David J Leffell; Allen E Bale; Susan T Mayne
Journal:  Ann Epidemiol       Date:  2014-05-22       Impact factor: 3.797

Review 4.  [Development of the immune system (author's transl)].

Authors:  J A Schwarz
Journal:  Klin Wochenschr       Date:  1974-09-15

5.  Factors in the differential rate of arteriosclerosis (AS) between long surviving renal transplant recipients and dialysis patients.

Authors:  F T Thomas; H M Lee
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

6.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

7.  Squamous dysplasia of the rectum in a patient with ulcerative colitis treated with 6-mercaptopurine.

Authors:  Rachel Greenberg; Bruce Greenwald; J Scott Roth; Olga Ioffe; Raymond Cross
Journal:  Dig Dis Sci       Date:  2007-08-24       Impact factor: 3.199

8.  Impact of altered endogenous IgG on unspecific mAb clearance.

Authors:  Saskia Fuhrmann; Charlotte Kloft; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-04-24       Impact factor: 2.745

9.  Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL.

Authors:  C Maurer; P Langerbeins; J Bahlo; P Cramer; A M Fink; N Pflug; A Engelke; J von Tresckow; G Kovacs; S Stilgenbauer; C-M Wendtner; L Müller; M Ritgen; T Seiler; K Fischer; M Hallek; B Eichhorst
Journal:  Leukemia       Date:  2016-05-02       Impact factor: 11.528

Review 10.  The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpoints.

Authors:  Santosha Vardhana; Anas Younes
Journal:  Haematologica       Date:  2016-07       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.